Accelerate Diagnostics Stock Down Despite FDA Clearance for Arc System [Yahoo! Finance]
Accelerate Diagnostics, Inc. (AXDX)
Last accelerate diagnostics, inc. earnings: 2/27 04:01 pm
Check Earnings Report
US:NASDAQ Investor Relations:
ir.axdx.com/investors
Company Research
Source: Yahoo! Finance
AXDX has secured FDA 510(k) clearance for its Accelerate Arc system and BC kit, designed for use with Bruker's MALDI Biotyper CA system (MBT-CA System) and MBT-CA Sepsityper software extension. Accelerate Diagnostics' automated platform simplifies the preparation of positive blood culture samples for direct microbial identification using Bruker's MBT-CA system, removing the overnight culture requirement. The Arc system reduces wait times for critical diagnostic results, which is essential in sepsis treatment. Accelerate Diagnostics completed the WAVE pre-clinical trial for its innovative WAVE system, which provides rapid antimicrobial susceptibility testing (AST) directly from positive blood culture bottles and isolated colonies.With sepsis affecting an estimated 49 million people globally each year and leading to around 11 million deaths, the WAVE system aims to enhance patient outcomes by enabling timely targeted antimicrobial therapy. This rapid testing not only improves patien
Show less
Read more
Impact Snapshot
Event Time:
AXDX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
AXDX alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
AXDX alerts
High impacting Accelerate Diagnostics, Inc. news events
Weekly update
A roundup of the hottest topics
AXDX
News
- Accelerate Diagnostics, Inc. (NASDAQ: AXDX) was upgraded by analysts at StockNews.com from a "sell" rating to a "hold" rating.MarketBeat
- Accelerate Diagnostics, Inc. (AXDX) Q3 2024 Earnings Call Transcript [Seeking Alpha]Seeking Alpha
- Accelerate Diagnostics (AXDX) Reports Q3 Loss, Lags Revenue Estimates [Yahoo! Finance]Yahoo! Finance
- Accelerate Diagnostics Reports Third Quarter 2024 Financial ResultsPR Newswire
- Accelerate Diagnostics, Inc. (NASDAQ: AXDX) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.MarketBeat
AXDX
Earnings
- 8/8/24 - Beat
AXDX
Sec Filings
- 11/14/24 - Form SC
- 11/7/24 - Form 10-Q
- 11/7/24 - Form 8-K
- AXDX's page on the SEC website